Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02278471 · ClinicalTrials.gov registry record · Phase 2
The SCCS Polypill Pilot Trial
A Phase 2 study of Hypertension and Hyperlipidemia, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 2
- Development phase
- 303
- Enrollment target
- 1
- Study location
NCT02278471 is a Phase 2 study of Hypertension and Hyperlipidemia that has completed, run by Vanderbilt University. The registered enrollment target is 303 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02278471, a Phase 2 study of Hypertension and Hyperlipidemia, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 303 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study the investigators will examine the effect of the polypill on medication adherence, systolic blood pressure, and LDL cholesterol over a 12 month span.
Conditions Studied
Interventions
- DRUG Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)
Study Locations (1)
Alabama
- Franklin Primary Health Center - Mobile
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-06-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02278471
The ClinicalTrials.gov registry entry for NCT02278471 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide) is the first listed.
NCT02278471 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT02278471 about?
NCT02278471 is a clinical study titled "The SCCS Polypill Pilot Trial". In this study the investigators will examine the effect of the polypill on medication adherence, systolic blood pressure, and LDL cholesterol over a 12 month span.
What is the current status of trial NCT02278471?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 303 participants. The study started on 2015-12. Estimated completion is 2018-06-27.
What conditions does trial NCT02278471 study?
This clinical trial studies the following conditions: Hypertension, Hyperlipidemia.
What interventions are being tested in trial NCT02278471?
The interventions under investigation include: Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide) (DRUG).
Who is sponsoring clinical trial NCT02278471?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02278471 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
RECRUITING · Phase 2
-
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
RECRUITING · Phase 2
-
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
RECRUITING · Phase 2
-
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
RECRUITING · Phase 2
-
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
RECRUITING · Phase 2
-
Virtual Diabetes Group Visits Across Health Systems
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.